Tag Archives: CRC

November, 2018

October, 2018

August, 2018

July, 2018

May, 2018

January, 2018

November, 2017

September, 2017

  • 15 September

    FDA Approves Amgen and Allergan’s Mvasi for the Treatment of Five Types of Cancer

    THOUSAND OAKS, Calif., Sept. 14, 2017 /PRNewswire/ — Amgen (NASDAQ: AMGN) and Allergan plc. (NYSE: AGN) today announced that the U.S. Food and Drug Administration (FDA) has approved MVASI™ (bevacizumab-awwb) for all eligible indications of the reference product, Avastin® (bevacizumab). MVASI is the first anti-cancer biosimilar, as well as the first bevacizumab biosimilar, approved by the FDA. MVASI is …

August, 2017

June, 2017